Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HNO International (HNOI) EBITDA (2022 - 2025)

HNO International (HNOI) has disclosed EBITDA for 4 consecutive years, with -$11.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 541.91% year-over-year to -$11.0 million, compared with a TTM value of -$6.4 million through Oct 2025, down 100.25%, and an annual FY2025 reading of -$6.4 million, down 100.31% over the prior year.
  • EBITDA was -$11.0 million for Q4 2025 at HNO International, down from -$431268.0 in the prior quarter.
  • Across five years, EBITDA topped out at $5.5 million in Q1 2025 and bottomed at -$11.0 million in Q4 2025.
  • Average EBITDA over 4 years is -$909456.9, with a median of -$444743.0 recorded in 2023.
  • Peak annual rise in EBITDA hit 1260.21% in 2025, while the deepest fall reached 541.91% in 2025.
  • Year by year, EBITDA stood at -$370531.0 in 2022, then tumbled by 155.54% to -$946840.0 in 2023, then plummeted by 81.68% to -$1.7 million in 2024, then crashed by 541.91% to -$11.0 million in 2025.
  • Business Quant data shows EBITDA for HNOI at -$11.0 million in Q4 2025, -$431268.0 in Q3 2025, and -$412527.0 in Q2 2025.